XML 46 R32.htm IDEA: XBRL DOCUMENT v3.24.3
Note 3 - Net Loss Per Share - Schedule of Antidilutive Securities (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Total potentially dilutive shares excluded from net income (loss) per share (in shares) 5,469,535 17,218,447 8,991,158 17,221,391
Convertible Senior Notes 2026 [Member]        
Total potentially dilutive shares excluded from net income (loss) per share (in shares) [1],[2] 5,293,414 12,172,008 8,882,651 12,172,008
Convertible Senior Notes 2023 [Member]        
Total potentially dilutive shares excluded from net income (loss) per share (in shares) [3] 0 4,941,739 0 4,941,739
Share-Based Payment Arrangement, Option [Member]        
Total potentially dilutive shares excluded from net income (loss) per share (in shares) 176,121 34,450 108,507 37,394
Restricted Stock Units (RSUs) [Member]        
Total potentially dilutive shares excluded from net income (loss) per share (in shares) [4] 0 70,250 0 70,250
[1] On June 3, 2024, we repurchased $118.1 million of our 2026 Notes reducing any effect of dilution related to those notes. For further details refer to “Note 6 — Debt.”
[2] The 2026 Notes are subject to a capped call arrangements that potentially reduces the dilutive effect of conversion as described in “Note 6 — Debt.” Any potential impact of the capped call arrangement is excluded from this table.
[3] The 2023 Notes (defined below) were fully extinguished upon maturity on November 15, 2023.
[4] The outstanding restricted stock units were vested and converted to shares of common stock on December 1, 2023.